WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Technology Software Products Sunday, August 19, 2018 
Add Press Release News | News Feeds Feeds | Email This News Email


Hypertrophic Cardiomyopathy Epidemiology Forecast Markets 2018-2028 by Gender & 5 Year Age Cohort
Friday, August 10, 2018

DUBLIN, Aug. 10, 2018 /PRNewswire/ --

The "Hypertrophic Cardiomyopathy Forecast In 26 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Hypertrophic cardiomyopathy (HCM) is a disease that contains an autosomal dominant inheritance pattern and is a moderately common transmitted genetic disease. The disease, characterised by hypertrophy in the left ventricle, cannot be explained by the presence of other clinical symptoms, such as hypertension.

This report provides the current prevalent population for HCM across 26 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Belgium, Norway, Sweden, Denmark, Austria, Switzerland, Ireland, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort.

Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of HCM. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of HCM have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for HCM include:

    --  Chronic heart failure
    --  Angina pectoris
    --  Atrial fibrillation

    --  Tachycardia

Reasons to buy

    --  Ability to quantify patient populations in global HCM market to target
        the development of future products, pricing strategies and launch plans.
    --  Further insight into the prevalence of the subdivided types of HCM and
        identification of patient segments with high potential.
    --  Delivery of more accurate information for clinical trials in study
        sizing and realistic patient recruitment for various countries.
    --  Better understanding on the impact of specific co-morbid conditions on
        the prevalent population of HCM patients.
    --  Identification of HCM patient sub-populations that require treatment.
    --  Better understanding of the specific markets that have the largest
        number of HCM patients.

Key Topics Covered:

    1. List Of Tables And Figures
    2. Introduction
    3. Cause Of The Disease
    4. Risk Factors & Prevention
    5. Diagnosis Of The Disease
    6. Variation By Geography/Ethnicity
    7. Disease Prognosis & Clinical Course
    8. Key Comorbid Conditions / Features Associated With The Disease
    9. Methodology For Quantification Of Patient Numbers
    10. Top-Line Prevalence For Hypertrophic Cardiomyopathy
    11. Features Of Hypertrophic Cardiomyopathy Patients
    12. Genetic Background
    13. Parameters And Symptoms
    14. Comorbidities Of Hypertrophic Cardiomyopathy Patients
    15. Abbreviations Used In The Report
    16. Other Publisher Services & Solutions
    17. Reports & Publications
    18. Online Epidemiology Databases
    19. Online Pharmaceutical Pricing Database
    20. References

    21. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/nx6pb5/hypertrophic?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/hypertrophic-cardiomyopathy-epidemiology-forecast-markets-2018-2028-by-gender--5-year-age-cohort-300695372.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav SecureLink Named to Inc. 5000 List of America's Fastest-Growing Private Companies | Aug 17, 2018
Nav The iWorld Expo 2018 Themed on Digital Economy Kicked Off in Chengdu | Aug 17, 2018
Nav Inc. Magazine Unveils Its 37th Annual List of America's Fastest-Growing Private Companies--the Inc. 5000 | Aug 17, 2018
Nav Eff Creative Group Recognized As An Inc. 500 Company For The Second Year In A Row; Ranks No. 408 On 2018 Inc. 5000 List | Aug 17, 2018
Nav Global Artificial Intelligence in Information and Communications Technology Intelligence Market 2018-2023 - Assess the AI Ecosystem, Technologies, Solutions and Market Outlook | Aug 17, 2018
Nav Global $34.3 Billion Entertainment and Leisure Robots Market to 2025 | Aug 17, 2018
Nav Beacon Capital Management Earns Spot on Inc. Magazine 37th Annual List of America's Fastest-Growing Private Companies | Aug 17, 2018
Nav Car Washing Services - Global Strategic Business Report 2016-2018 to 2024: Featuring 145 Key & Niche Player Profiles | Aug 17, 2018
Nav Global Baked Foods & Cereals Intelligence Database 2010-2023 | Aug 17, 2018
Nav Global Dairy Intelligence Database 2018: 13 Years of Comparable Data with 5 Year Forecasts | Aug 17, 2018
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News